QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug-Induced Hepatotoxicity in Chinese Patients 期刊论文 JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 卷号: 59, 期号: 7, 页码: 1014-1021 作者:  He, Xiaomin[1];  Zhang, Haiping[2];  Tao, Bilin[3];  Yang, Miaomiao[4];  Chen, Hongbo[5] 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/24 antituberculosis drug  exportin 1  hepatotoxicity  tagSNP   Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study 期刊论文 JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 卷号: 44, 期号: 4, 页码: 534-542 作者:  Yang, Miaomiao[1];  Zhang, Haiping[2];  Tao, Bilin[3];  Pan, Hongqiu[4];  Lu, Lihuan[5] 收藏  |  浏览/下载：30/0  |  提交时间：2019/12/24 anti-tuberculosis drug  hepatotoxicity  HMOX1  NQO1  polymorphisms   Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population 期刊论文 PHARMACOGENETICS AND GENOMICS, 2019, 卷号: 29, 期号: 4, 页码: 84-90 作者:  Pan, Hongqiu[1];  Yang, Miaomiao[2];  Lu, Lihuan[3];  Tao, Bilin[4];  He, Xiaomin[5] 收藏  |  浏览/下载：36/0  |  提交时间：2019/12/24 AGBL4  antituberculosis drug  CUX2  FAM65B  hepatotoxicity   Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study 期刊论文 BMJ OPEN, 2019, 卷号: 9, 期号: 3, 页码: e027321 作者:  Yang, Miaomiao[1];  Pan, Hongqiu[2];  Lu, Lihuan[3];  He, Xiaomin[4];  Chen, Hongbo[5] 收藏  |  浏览/下载：21/0  |  提交时间：2019/12/24 adverse drug reactions  anti-tuberculosis treatment  prospective observational study   Treatment outcome of a shorter regimen containing clofazimine for multidrug-resistant tuberculosis: a randomized control trial in China 期刊论文 2019 作者:  Du Yadong;  Qiu Chao;  Chen Xiaohong;  Wang Jing;  Jing Wei 收藏  |  浏览/下载：75/0  |  提交时间：2020/01/03 clofazimine  multidrug-resistant  outcome  safety  tuberculosis   Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China 期刊论文 2019, 卷号: 12, 页码: 763-770 作者:  Wang, Jing;  Pang, Yu;  Jing, Wei;  Chen, Wei;  Guo, Ru 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03 multidrug-resistant tuberculosis  cycloserine  treatment  China  adverse events